Clinical Study
A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy
Table 2
Surgical procedures and outcomes of participants with or without conbercept pretreatment.
| | Preoperative intravitreal conbercept () | Control () | value |
| Severity of intraoperative bleeding grade | | | 0.002 | 3 | 3 | 10 | | 2 | 10 | 22 | | 1 | 27 | 14 | | 0 | 14 | 7 | | Recurrent VH | | | | ≤4 weeks | 9 (16.67%) | 26 (49.05%) | 0.000 | Severity of recurrent VH grade | | | 0.000 | 4 | 0 | 1 | | 3 | 0 | 2 | | 2 | 2 | 8 | | 1 | 7 | 15 | | >4 weeks | 6 (11.11%) | 8 (15.01%) | 0.973 | Severity of recurrent VH grade | | | 0.732 | 4 | 0 | 0 | | 3 | 0 | 1 | | 2 | 2 | 3 | | 1 | 4 | 4 | |
|
|
VH: vitreous hemorrhage.
|